Company Urologix, Inc. Other OTC
Equities
ULGX
US9172731047
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
Medical Products
100.0
%
| 17 | 100.0 % | 14 | 100.0 % | -14.20% |
Sales per region
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 17 | 100.0 % | 14 | 100.0 % | -14.20% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 91-05-28 |
Scott Madson
DFI | Director of Finance/CFO | 63 | 15-03-31 |
Lisa Ackermann
SAM | Sales & Marketing | 51 | 11-06-15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 91-05-28 |
Sidney Emery
BRD | Director/Board Member | 74 | 05-09-30 |
Director/Board Member | 57 | 10-08-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,817,726 | 21,817,726 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Urologix, Inc.
14405 21st Avenue North
55447-4699, Minneapolis
+
![address Urologix, Inc.(ULGX)](https://cdn.zonebourse.com/static/address/13370545.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+6.37% | 216B | |
+10.21% | 189B | |
+28.22% | 153B | |
+34.42% | 114B | |
+19.21% | 54.78B | |
+0.13% | 48.47B | |
-4.16% | 38.88B | |
+2.39% | 36.14B | |
+19.65% | 30.23B |